Ozempic and Wegovy are widely used to support weight loss and manage diabetes. But could this class of drugs, known as GLP-1 receptor agonists, also help treat heart failure, liver disease and even addiction?

A new study by researchers at McGill University and the Lady Davis Institute for Medical Research at the Jewish General Hospital takes a closer look at their growing list of potential uses beyond diabetes and obesity.